Patents by Inventor Laura Kline

Laura Kline has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NANOPARTICULATE MELOXICAM FORMULATIONS
    Publication number: 20210113580
    Abstract: The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: June 5, 2020
    Publication date: April 22, 2021
    Inventors: Eugene R. COOPER, Tuula RYDE, John PRUITT, Laura KLINE
  • Nanoparticulate meloxicam formulations
    Patent number: 10709713
    Abstract: The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
    Type: Grant
    Filed: August 25, 2019
    Date of Patent: July 14, 2020
    Assignee: BAUDAX BIO, INC.
    Inventors: Eugene R. Cooper, Tuula Ryde, John Pruitt, Laura Kline
  • Nanoparticulate Meloxicam Formulations
    Publication number: 20200155564
    Abstract: The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: July 10, 2019
    Publication date: May 21, 2020
    Inventors: Eugene R. Cooper, Tuula Ryde, John Pruitt, Laura Kline
  • Nanoparticulate Meloxicam Formulations
    Publication number: 20190381062
    Abstract: The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: August 25, 2019
    Publication date: December 19, 2019
    Inventors: Eugene R. Cooper, Tuula Ryde, John Pruitt, Laura Kline
  • Nanoparticulate meloxicam formulations
    Patent number: 10471067
    Abstract: The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
    Type: Grant
    Filed: February 21, 2017
    Date of Patent: November 12, 2019
    Assignee: Recro Pharma, Inc.
    Inventors: Eugene R. Cooper, Tuula Ryde, John Pruitt, Laura Kline
  • Nanoparticulate meloxicam formulations
    Patent number: 10463673
    Abstract: The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
    Type: Grant
    Filed: April 11, 2018
    Date of Patent: November 5, 2019
    Assignee: Recro Pharma, Inc.
    Inventors: Eugene R. Cooper, Tuula Ryde, John Pruitt, Laura Kline
  • Nanoparticulate Meloxicam Formulations
    Publication number: 20180228810
    Abstract: The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: April 11, 2018
    Publication date: August 16, 2018
    Inventors: Eugene R. Cooper, Tuula Ryde, John Pruitt, Laura Kline
  • Nanoparticulate Meloxicam Formulations
    Publication number: 20180228809
    Abstract: The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: April 11, 2018
    Publication date: August 16, 2018
    Inventors: Eugene R. Cooper, Tuula Ryde, John Pruitt, Laura Kline
  • Nanoparticulate Meloxicam Formulations
    Publication number: 20170157061
    Abstract: The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: February 21, 2017
    Publication date: June 8, 2017
    Inventors: Eugene R. Cooper, Tuula Ryde, John Pruitt, Laura Kline
  • NANOPARTICULATE MELOXICAM FORMULATIONS
    Publication number: 20140141083
    Abstract: The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: July 12, 2013
    Publication date: May 22, 2014
    Inventors: Eugene R. Cooper, Tuula Ryde, John Pruitt, Laura Kline
  • Nanoparticulate meloxicam formulations
    Patent number: 8512727
    Abstract: The present invention is directed to nanoparticulate compositions comprising meloxicam. The meloxicam particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Grant
    Filed: February 24, 2004
    Date of Patent: August 20, 2013
    Assignee: Alkermes Pharma Ireland Limited
    Inventors: Eugene R. Cooper, Tuula Ryde, John Pruitt, Laura Kline
  • NANOPARTICULATE MELOXICAM FORMULATIONS
    Publication number: 20100297252
    Abstract: The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: May 26, 2010
    Publication date: November 25, 2010
    Inventors: Eugene R. Cooper, Tuula Ryde, John Pruitt, Laura Kline
  • Nanoparticulate polycosanol formulations and novel polycosanol combinations
    Patent number: 7763278
    Abstract: The present invention is directed to nanoparticulate compositions comprising one or more polycosanols. The polycosanol particles of the composition have an effective average particle size of less than about 2000 nm. In another aspect of this invention, novel combinations of polycosanols and other cholesterol lowering agents are described and methods of using same are taught.
    Type: Grant
    Filed: June 10, 2003
    Date of Patent: July 27, 2010
    Assignee: Elan Pharma International Ltd.
    Inventors: Eugene R. Cooper, Laura Kline, Gary G. Liversidge, Niels P. Ryde
  • NANOPARTICULATE POLYCOSANOL FORMULATIONS & NOVEL POLYCOSANOL COMBINATIONS
    Publication number: 20100143962
    Abstract: The invention provides a culture device comprising a plurality of culture units, wherein each unit comprises a culture chamber, an inlet port for liquid supply of the culture and an outlet port for discharging liquid from the unit, wherein the inlet port is in fluid communication with the culture chamber and the culture chamber is in fluid communication with the outlet port for allowing a liquid flow through the culture chamber. The culture device is particularly suitable for testing immune cells and immunofunction in vitro. Aspects of the invention include a culture device and associated methods for cultivating immune cells and an in vitro method of analysing the effect of a test compound on immune cells.
    Type: Application
    Filed: February 11, 2010
    Publication date: June 10, 2010
    Inventors: Eugene R. COOPER, Laura Kline, Gary G. Liversidge, Niels P. Ryde
  • NANOPARTICULATE COMPOSITIONS OF MITOGEN-ACTIVATED PROTEIN (MAP) KINASE INHIBITORS
    Publication number: 20060193920
    Abstract: Nanoparticulate compositions comprising at least one poorly soluble MAP kinase inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making and using such compositions.
    Type: Application
    Filed: December 7, 2005
    Publication date: August 31, 2006
    Inventors: H. Bosch, Greta Cary, Douglas Hovey, Rajeev Jain, Laura Kline, Elaine Merisko-Liversidge, Kevin Ostrander
  • Nanoparticulate meloxicam formulations
    Publication number: 20040229038
    Abstract: The present invention is directed to nanoparticulate compositions comprising meloxicam. The meloxicam particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: February 24, 2004
    Publication date: November 18, 2004
    Applicant: Elan Pharma International Ltd.
    Inventors: Eugene R. Cooper, Tuula Ryde, John Pruitt, Laura Kline
  • Gamma irradiation of solid nanoparticulate active agents
    Publication number: 20040105778
    Abstract: The present invention relates to methods for terminal sterilization of solid forms of nanoparticulate active agent compositions via gamma irradiation. The nanoparticulate active agent has an effective average particle size of less than about 2 microns, prior to incorporation into a solid form for sterilization. The resultant sterilized compositions exhibit excellent redispersibility, homogeneity, and uniformity. Also encompassed are compositions made via the described method and methods of treating animals and humans using such compositions.
    Type: Application
    Filed: September 4, 2003
    Publication date: June 3, 2004
    Applicant: Elan Pharma International Limited
    Inventors: Robert Lee, Matthew Hilborn, Laura Kline, Janine Keller
  • Nanoparticulate sterol formulations and novel sterol combinations
    Publication number: 20040033202
    Abstract: The present invention is directed to nanoparticulate compositions comprising one or more sterols or stanols, such as sitosterol or phytosterol. The sterol particles of the composition have an effective average particle size of less than about 2000 nm. In another aspect of this invention, novel combinations of sterols and other cholesterol lowering agents are described and methods of using same are taught.
    Type: Application
    Filed: June 10, 2003
    Publication date: February 19, 2004
    Applicant: Elan Pharma International, Ltd.
    Inventors: Eugene R. Cooper, Laura Kline, Gary G. Liversidge, Niels P. Ryde
  • Nanoparticulate polycosanol formulations & novel polycosanol combinations
    Publication number: 20030232796
    Abstract: The present invention is directed to nanoparticulate compositions comprising one or more polycosanols. The polycosanol particles of the composition have an effective average particle size of less than about 2000 nm. In another aspect of this invention, novel combinations of polycosanols and other cholesterol lowering agents are described and methods of using same are taught.
    Type: Application
    Filed: June 10, 2003
    Publication date: December 18, 2003
    Applicant: Elan Pharma International, Ltd.
    Inventors: Eugene R. Cooper, Laura Kline, Gary G. Liversidge, Niels P. Ryde